MERCALIS RELEASES 2023 ANNUAL HIGHLIGHTS [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
solutions that span the entire biopharmaceutical value chain, today released its 2023 annual highlights, detailing the organization's impressive performance over the past year. In September, TrialCard announced it had rebranded to become Mercalis, a transformation several years in the making. Over time, the Mercalis executive leadership team implemented a deliberate strategy to expand its capabilities to support life sciences companies more comprehensively in a rapidly evolving marketplace. Years of robust organic growth and purposeful inorganic expansion, including seven acquisitions over the past five years, further diversified the company beyond patient support into broader life sciences commercialization services. This transformation culminated in the launch of a new brand—Mercalis—to encompass it all. "Mercalis's success in 2023 was highlighted by a pivotal corporate rebranding," said Scott Dulitz , Mercalis's Chief Executive Officer. "The year represented a significant strid
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story [Seeking Alpha]Seeking Alpha
- OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]Yahoo! Finance
- OptimizeRx Continues Expansion of the Company’s Point-Of-Care NetworkGlobeNewswire
- OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=OPRX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a>MarketBeat
OPRX
Earnings
- 11/6/25 - Beat
OPRX
Sec Filings
- 12/23/25 - Form 4/A
- 12/23/25 - Form 4
- 12/23/25 - Form 4
- OPRX's page on the SEC website